Departamento
- Medicina Experimental
Publicaciones (67) Publicaciones en las que ha participado algún/a investigador/a
2023
-
A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens
Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 48
-
A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies
Journal of Neurology, Vol. 270, Núm. 5, pp. 2380-2391
-
Abordaje Volar de las Fracturas de Radio Distal y la Vaina del Flexor Carpi Radialis. Una Encuesta Regional y Nacional
Revista iberoamericana de cirugía de la mano, Vol. 51, Núm. 1, pp. 16-22
-
Adult neurogenesis in the telencephalon of the lizard Podarcis liolepis
Frontiers in Neuroscience, Vol. 17
-
Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study
European Archives of Psychiatry and Clinical Neuroscience
-
Antihypertensive Effects of an Optimized Aged Garlic Extract in Subjects with Grade I Hypertension and Antihypertensive Drug Therapy: A Randomized, Triple-Blind Controlled Trial
Nutrients, Vol. 15, Núm. 17
-
Applications of CRISPR Technology to Breast Cancer and Triple Negative Breast Cancer Research
Cancers, Vol. 15, Núm. 17
-
Associations of Dietary Intake and Nutrient Status with Micronutrient and Lipid Composition in Breast Milk of Donor Women
Nutrients, Vol. 15, Núm. 15
-
Breathing cessation events that compose the apnea-hypopnea index are distinctively associated with the adverse outcomes in Alzheimer's disease
Alzheimer's research & therapy, Vol. 15, Núm. 1, pp. 123
-
COVID-19 severity is related to poor executive function in people with post-COVID conditions
Journal of Neurology, Vol. 270, Núm. 5, pp. 2392-2408
-
Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease
Science translational medicine, Vol. 15, Núm. 712, pp. eabn5939
-
Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer's disease
Alzheimer's research & therapy, Vol. 15, Núm. 1, pp. 134
-
Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer’s Disease
Aging and Disease, Vol. 14, Núm. 5, pp. 1728-1738
-
Comparison of heart, grace and TIMI scores to predict major adverse cardiac events from chest pain in a Spanish health care region
Scientific Reports, Vol. 13, Núm. 1
-
Cumulative tobacco consumption has a dose-dependent effect on atheromatosis burden and improves severe atheromatosis prediction in asymptomatic middle-aged individuals: The ILERVAS study
Atherosclerosis, Vol. 375, pp. 75-83
-
Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2
Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 10
-
Dietary Advanced Glycation End Products: Their Role in the Insulin Resistance of Aging
Cells, Vol. 12, Núm. 13
-
ERK MAPK signaling pathway inhibition as a potential target to prevent autophagy alterations in Spinal Muscular Atrophy motoneurons
Cell Death Discovery, Vol. 9, Núm. 1
-
El ojo cooperativo
Mètode: Revista de difusión de la Investigación, Vol. 2, Núm. 117, pp. 108-108
-
Ether Lipid-Mediated Antioxidant Defense in Alzheimer’s Disease
Antioxidants, Vol. 12, Núm. 2